ARTICLE | Clinical News
Relistor methylnaltrexone regulatory update
June 15, 2015 7:00 AM UTC
The European Commission approved an expanded label for subcutaneous Relistor methylnaltrexone from Valeant and Progenics to treat opioid-induced constipation (OIC) in adults when response to laxative ...